IP Library Granted Patent US 8,604,206
Granted Patent B2
US 8,604,206 · App. 12/898,112 · Granted Dec 10, 2013

Compositions for preventing and/or treating degenerative disorders of the central nervous system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,604,206
App. No.
12/898,112
Granted
Dec 10, 2013
Kind
B2
Abstract

The present invention provides novel compounds as well as compositions and methods using the same for preventing and/or treating degenerative disorders of the central nervous system. In particular, the present invention provides methods for preventing and/or treating Parkinson's disease.

Claims (20)

1. A compound selected from the following:

or a pharmaceutically acceptable salt, or solvate thereof.

2. The compound of claim 1 which is:

or a pharmaceutically acceptable salt, or solvate thereof.

3. The compound of claim 1 which is:

or a pharmaceutically acceptable salt, or solvate thereof.

4. The compound of claim 1 which is:

or a pharmaceutically acceptable salt, or solvate thereof.

5. The compound of claim 1 which is:

or a pharmaceutically acceptable salt, or solvate thereof.

6. A pharmaceutical composition comprising at least one pharmaceutically acceptable carrier and a compound selected from:

or a pharmaceutically acceptable salt, or solvate thereof.

7. A pharmaceutical composition comprising at least one pharmaceutically acceptable carrier and a compound selected from:

or a pharmaceutically acceptable salt, or solvate thereof.

8. The pharmaceutical composition of claim 7 , wherein the compound is:

or a pharmaceutically acceptable salt, or solvate thereof.

9. The pharmaceutical composition of claim 7 , wherein the compound is:

or a pharmaceutically acceptable salt, or solvate thereof.

10. The pharmaceutical composition of claim 7 , wherein the compound is:

or a pharmaceutically acceptable salt, or solvate thereof.

Assignments (3)
SECURITY INTEREST Recorded Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →
RELEASE OF SECURITY INTEREST Recorded Apr 27, 2026
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 075494/0030 →
SECURITY INTEREST Recorded Oct 6, 2023
From: AMICUS THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 065177/0196 →